Since SYF2 was reported to be relevant for cell cycle progression by modulating transcriptional and posttranscriptional control of α-tubulin and cycline D1 [6, 8, 14], we postulated that SYF2 expression would have a similar proliferative effect on BC cells. The gene discussed is CCND1; the disease is breast cancer.